Purchase Order HT001425PE112
Award Date 9/30/25
Potential Completion Date 10/30/25
Potential Value $139K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $139,428.00 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biotheranostics Inc., a self-certified small disadvantaged business. The contract is for the provision of Biotheranostics' proprietary Breast Cancer Index genomic diagnostic testing services to support cancer care for the DHA's beneficiary population. This contract award represents one of several prime federal awards, totaling over $700,000 between 2021-2023, that Biotheranostics has received...
- This is a $256,599.00 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Biotheranostics Inc., a self-certified small disadvantaged business and division of Hologic, Inc. The contract is for the provision of the Breast Cancer Index (BCI) diagnostic test. The BCI test leverages genomic analysis to aid in cancer screening, diagnosis, and treatment planning. This award is not set aside and is one of several prime federal...
- The Defense Health Agency awarded Genomic Health, Inc. a $145,066.32 firm fixed-price BPA call for Oncotype IQ genomic testing services, with an ultimate completion date of September 7, 2026. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in advanced genetic testing services focused on oncology diagnostics, particularly the Oncotype DX portfolio of gene expression assays. These tests support cancer screening, treatment selection, and disease monitoring across breast,...
- This federal contract award to Genomic Health, Inc. is for the provision of breast cancer testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $125,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) contract does not utilize any set-aside designations and was awarded on September 21, 2016, with a completion date of September 20, 2017. Genomic Health, a subsidiary of Exact Sciences Corporation, specializes in genomic-based cancer...
- The Defense Health Agency awarded a $145,066 firm fixed price blanket purchase agreement call contract to Genomic Health, Inc., a division of Exact Sciences Corporation, to deliver its Oncotype Portfolio of genomic tests for earlier cancer detection and cancer treatment. The testing portfolio aims to support the Defense Health Agency's efforts to advance cancer screening and personalized treatment selection. Performance will occur in Bethesda, Maryland over one year effective September 2023....
- This federal contract award is for Oncotype DX breast cancer testing services provided by Genomic Health, Inc. to the Defense Health Agency. The $13,815.84 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call, with a performance period ending on May 31, 2018. Genomic Health, a subsidiary of Exact Sciences Corporation, is a for-profit organization that specializes in providing advanced genetic testing services to federal healthcare systems. The company has several large Indefinite...
- This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX breast cancer testing services. The contract has an ultimate completion date of February 8, 2018 and a ceiling value of $10,361.88. Genomic Health, Inc. is a for-profit organization that specializes in advanced genetic testing services for federal healthcare systems. The company has been awarded several...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for the provision of "Oncotype Testing" services to support cancer diagnoses at the Fort Belvoir Community Hospital's Anatomic Pathology Department. The contract has a potential value of $250,000.00 and a period of performance running from the award date of October 17, 2020 through October 16, 2021. No set-aside designation was...
- This is a federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of the Oncotype portfolio of genomic tests to support patient care in anatomic pathology. The contract has a ceiling value of $145,066.32 and was awarded by the Defense Health Agency, a defense agency, on September 8, 2024. The contract type is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure, and an ultimate completion date of September 7,...
- This contract was awarded by the Defense Health Agency to Genomic Health, Inc., a developer and manufacturer of genomic and diagnostic tests for cancer detection and treatment. The contract provides for medical laboratory testing and analysis services, including Genomic Health's Oncotype DX Breast and Oncotype DX Colon cancer tests. The contract was awarded as a Blanket Purchase Agreement (BPA) call on a Firm Fixed Price basis, with a potential value of $125,000.00. The contract does not utilize...